{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:15:05Z","timestamp":1649016905012},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1093\/tropej\/fmi105","type":"journal-article","created":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T20:24:09Z","timestamp":1133814249000},"page":"227-228","source":"Crossref","is-referenced-by-count":0,"title":["Serum Level of Antioxidant Taurine in \u03b2-Thalassaemia Subjects: Possible Protection Against Thalassaemia Complications"],"prefix":"10.1093","volume":"52","author":[{"given":"Mahmoud M.","family":"Sirdah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel Nasser K.","family":"Abu Shahla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Khoudair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim M. A.","family":"El-Agouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,12,5]]},"reference":[{"key":"key\n\t\t\t\t20171013210244_BIB1","doi-asserted-by":"crossref","unstructured":"Weatherall D. Pathophysiology of thalassaemia. Baillieres Clin Haematol1998;11(1):127\u201346.","DOI":"10.1016\/S0950-3536(98)80072-3"},{"key":"key\n\t\t\t\t20171013210244_BIB2","unstructured":"Grinberg L, Rachmilewitz E. (eds) Beuzard Y, Lubin B, Rosa J. Oxidative stress in \u03b2-thalassemic red blood cells and potential use of antioxidants. In: Sickle Cell Disease and Thalassaemia: New Trends in Therapy. London: Colloque INSERM\/John Libby Eurotext. 1995,519\u201324."},{"key":"key\n\t\t\t\t20171013210244_BIB3","doi-asserted-by":"crossref","unstructured":"Timbrell J, Seabra V, Waterfield C. The in vivo and in vitro protective properties of taurine. Gen Pharmacol1995;26(3):453\u201362.","DOI":"10.1016\/0306-3623(94)00203-Y"},{"key":"key\n\t\t\t\t20171013210244_BIB4","unstructured":"Birdsall T. Therapeutic applications of taurine. Altern Med Rev1998;3(2):128\u201336."}],"container-title":["Journal of Tropical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/tropej\/article-pdf\/52\/3\/227\/4752393\/fmi105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T04:53:44Z","timestamp":1554785624000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/tropej\/article\/52\/3\/227\/1698482\/Serum-Level-of-Antioxidant-Taurine-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,5]]},"references-count":4,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,12,5]]},"published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/tropej\/fmi105","relation":{},"ISSN":["1465-3664","0142-6338"],"issn-type":[{"value":"1465-3664","type":"electronic"},{"value":"0142-6338","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,6]]},"published":{"date-parts":[[2005,12,5]]}}}